Cancer Support Group

Tuesday, Apr 20th

Last update:06:42:40 AM GMT

Year 2014

Now, an affordable cancer detection kit

Indian Institute of Science founded Strand Life Sciences in partnership with the Mazumdar-Shaw Medical Foundation has developed a cancer diagnostic kit that can assess the likely occurrence of the chronic disease at one-fourth of the current diagnostic costs.

Bangalore-based Strand, a technology company in the field of genomics, has patented intellectual property to help early detection of breast and ovarian cancer among Indian patients by analyzing DNA sequences.

Heredity is a major factor in the recurrence of cancer through generations. Brca I, Brca II, and TP53 are the three genes that can mutate and cause breast or ovarian cancer.

Breast cancer is the most prevalent cancer among Indian women with approximately 1.5 lakh new patients being diagnosed every year. Nearly 7 lakh Indians die of some form of cancer every year, while over 10 lakh are newly diag nosed with the disease.


Page 3 of 4


This is YOUR sites, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Make a Suggestion
Manthan Award

Link to Aarogya

aarogya logo